Abstract:Over the last century, there have been major landmark developments in the field of medicine, enabling us to control and cure various diseases on a larger scale. A few of these include the discovery of antibiotics, the development of vaccines, and the origin of organ and tissue transplants. The continued quest for innovation in microbiology and medicine has helped humankind save millions of lives and decrease morbidity at the global level. Genetic medicine has grown significantly in the last two decades and appears to be the next frontier of curative therapies for chronic diseases. One important landmark in genetic medicine is the development of CRISPR (clustered, regularly interspaced short palindromic repeats) technology. In this article, we describe the basic structure and function of the CRISPR-Cas9 system, which, simply put, consists of an RNA part and a protein. It works as a molecular scissor that can perform targeted cuts followed by repairs in and around the genes of interest to attain favorable translational outcomes. We focused on summarizing recent studies using CRISPR-Cas9 technology in diagnosing and treating cardiovascular disease. These studies are primarily experimental and limited to animal models. However, their results are promising enough to anticipate that this technology will undoubtedly be available in clinical medicine in the coming years. CRISPR-Cas9-mediated gene editing has been used to study and potentially treat congenital heart disease, hyperlipidemias, arrhythmogenic cardiomyopathies, and the prevention of ischemia-reperfusion injury. Despite the current progress, we recognize the several challenges this technology faces, including funding for research, improving precision and reproducible results for human subjects, and establishing protocols for ethical compliance so that it is acceptable to the scientific community and the general public.

hPSC gene editing for cardiac disease therapy

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Human-induced Pluripotent Stem Cells As Models for Rare Cardiovascular Diseases: from Evidence-Based Medicine to Precision Medicine

CRISPR/CAS9: A promising approach for the research and treatment of cardiovascular diseases

Gene Editing Therapy for Cardiovascular Diseases

A glance at the application of CRISPR/Cas9 gene-editing technology in cardiovascular diseases

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery

A new era of clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 gene editing technology in cardiovascular diseases: Opportunities, challenges, and perspectives

Genomic Engineering of Induced Pluripotent Stem Cell-Derived Cardiomyocytes

The Use of CRISPR-Cas9 Genetic Technology in Cardiovascular Disease: A Comprehensive Review of Current Progress and Future Prospective

Modified mRNA-based gene editing reveals sarcomere-based regulation of gene expression in human induced-pluripotent stem cell-derived cardiomyocytes

The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research

Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling

Potential Applications Of Induced Pluripotent Stem Cells For Cardiovascular Diseases

Integrating Prime Editing and Cellular Reprogramming as Novel Strategies for Genetic Cardiac Disease Modeling and Treatment

Development and application of CRISPR/Cas9 technologies in genomic editing.

Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy

Gene editing in common cardiovascular diseases

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

Advances in the Generation of Constructed Cardiac Tissue Derived from Induced Pluripotent Stem Cells for Disease Modeling and Therapeutic Discovery

Applications of Genetically Engineered Human Pluripotent Stem Cell Reporters in Cardiac Stem Cell Biology